The American Heart Association recently endorsed guidelines that lower the diagnostic criteria for chronic hypertension outside of pregnancy to 130/80 mm Hg. We investigated the relationship between blood pressure (BP) during the first half of pregnancy and maternal-fetal outcomes. We hypothesized that using the same lower diagnostic threshold of BP 130/80 mm Hg prior to 20 weeks gestation would identify women at increased risk for adverse maternal and fetal outcomes compared with normotensive controls. STUDY DESIGN: We conducted a retrospective cohort study of women with singleton pregnancies who received prenatal care and delivered at a single tertiary care center from 2010-2017. Women were categorized into three distinct groups based on their BP status. Group 1: Women with chronic hypertension based on current ACOG guidelines (existing diagnosis of chronic hypertension or BP 140/90 mm Hg prior to 20 weeks gestation). Group 2: Women with no prepregnancy diagnosis of hypertension, but with systolic BP 130 mm Hg or diastolic BP 80 mm Hg on two occasions prior to 20 weeks gestation. Group 3: Normotensive controls. Maternal and fetal outcomes were collected and compared between groups. The primary outcome was development of preeclampsia. One-way ANOVA was used to compare groups for continuous outcomes and logistic regression analyses were used to compare groups for categorical outcomes. RESULTS: Of the 3,761 women that met criteria for study entry, 134 were found to have chronic hypertension based on current guidelines (group 1), 327 had BP 130/80 mm Hg prior to 20 weeks gestation (group 2), and 3300 were normotensive controls (group 3). Women in groups 1 and 2 had similar demographic characteristics. (Table 1) . They were more likely to be older, have a higher prepregnancy BMI, and have pregestational diabetes. 25.4% of women in group 1 and 15% of women in group 2 developed preeclampsia as compared to 4.8% of controls (p<0.001). Women in group 2 were also more likely to develop gestational hypertension, gestational diabetes, deliver preterm, and undergo cesarean delivery than were controls. (Table 2) . CONCLUSION: Women with BP 130/80 mm Hg prior to 20 weeks gestation are at increased risk for developing hypertensive disorders of pregnancy. Additional analyses will clarify if blood pressure prior to 20 weeks gestation is an independent predictor of preeclampsia. 
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To determine whether women with hypertensive disorders of pregnancy who present hypertensive to their 2-12 weeks postpartum visit are at greater risk for hypertension within the 2 years following their deliveries. STUDY DESIGN: Retrospective cohort study of women with hypertensive disorders during pregnancy delivering at our institution between July 1, 2009 and July 1, 2016. Women were included if they had at least one recorded blood pressure in the 2-12 weeks following delivery and one recorded blood pressure between 12 weeks and 24 months postpartum. Hypertension was defined as one value of systolic blood pressure greater than or equal to 140 or diastolic value greater than or equal to 90 during the time frame listed. Chi square was used to compare categorical variables and Student's t test for continuous. A logistic regression model was used to determine the odds of hypertension in the 2 years following delivery when subjects remained hypertensive in the 2-12 weeks postdelivery. Multivariable logistic regression analysis was used to adjust for confounding factors including maternal age, pre-pregnancy BMI, parity, smoking status, antepartum and intrapartum hypertension therapy, occurrence of pre-labor rupture of membranes, gestational age, and type of hypertension disorder. RESULTS: A cohort of 449 women was identified. Hypertension in the 2-12 weeks following delivery occurred in 86 (19%) of women. Hypertension at a visit between 2-12 weeks was associated with a 2.6-fold increased risk of continued hypertension in the 12 weeks to 24 months post-delivery (OR 2.65[1.6-4.3], p <0.001). In the adjusted analysis, hypertension had a 1.9-fold increased risk of having hypertension at 12 weeks to 24 months ], p¼0.027) after controlling for potential demographic and clinical confounders. CONCLUSION: Our data show that women who have hypertension noted between 2-12 weeks post-delivery have higher rates of continued hypertension up to 2 years from delivery. It is important to counsel these women on this risk at their postpartum follow up visits and encourage appropriate follow up with their primary care providers.
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